Longboard Pharmaceuticals
Stock Forecast, Prediction & Price Target

Longboard Pharmaceuticals Financial Estimates

Longboard Pharmaceuticals Revenue Estimates

Longboard Pharmaceuticals EBITDA Estimates

Longboard Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $2.58M
Low: $2.58M
High: $2.58M
avg. 0%
Avg: $4.83M
Low: $4.83M
High: $4.83M
avg. 87.38%
Avg: $66.06M
Low: $66.06M
High: $66.06M
avg. 1266.58%
Avg: $261.05M
Low: $261.05M
High: $261.05M
avg. 295.14%
Net Income
 
% change YoY
$-27.73M
 
N/A
$-43.09M
 
-55.38%
$-54.42M
 
-26.29%
Avg: $-91.01M
Low: $-62.27M
High: $-38.88M
avg. -67.23%
Avg: $-115.99M
Low: $-76.58M
High: $-45.22M
avg. -27.44%
Avg: $-62.57M
Low: $-62.57M
High: $-62.57M
avg. 46.05%
Avg: $-12.72M
Low: $-12.72M
High: $-12.72M
avg. 79.66%
EBITDA
 
% change YoY
$-27.83M
 
N/A
$-44.79M
 
-60.92%
$-56.75M
 
-26.68%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.62
 
N/A
-$2.51
 
-54.93%
-$2.39
 
4.78%
Avg: -$2.28
Low: -$2.74
High: -$1.71
avg. 4.41%
Avg: -$2.63
Low: -$3.37
High: -$1.99
avg. -15.33%
Avg: -$2.75
Low: -$2.75
High: -$2.75
avg. -4.50%
Avg: -$0.56
Low: -$0.56
High: -$0.56
avg. 79.66%
Operating Expenses
 
% change YoY
$27.83M
 
N/A
$44.79M
 
60.91%
$56.75M
 
26.69%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Longboard Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 7.75% in 2025-2028.

We have gathered data from 6 analysts. Their low estimate is -62.27M, average is -91.01M and high is -38.88M.

What is Longboard Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 412.27% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is $2.58M, average is $2.58M and high is $2.58M.

What is Longboard Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 16.06% in 2025-2028.

We have gathered data from 6 analysts. Their low earnings per share estimate is -$2.74, average is -$2.28 and high is $-1.71.

What is the best performing analyst?

In the last twelve months 1 analysts have been covering Longboard Pharmaceuticals stock. The most successful analyst is Kalpit Patel.